| Oseltamivir impurity B | Not available | C16H29N5O4 |
| Oseltamivir impurity C | 187227-45-8 | C14H24N2O4 |
| Oseltamivir impurity C | 187227-45-8 | C14H24N2O4 |
| Oseltamivir Impurity E | 903907-74-4 | C11H18N2O4 |
| Oseltamivir impurity H | 814-29-9 | C12H27OP |
| Oseltamivir Impurity I | 212504-89-7 | C14H26N2O3 |
| Oseltamivir Impurity-RRE | 1266663-89-1 | C14H22O4 |
| Oseltamivir Impurity-RSE | 2413185-89-2 | C14H22O4 |
| Oseltamivir Impurity-SSE | 2413185-88-1 | C14H22O4 |
| Oseltamivir Intermediate 2 | 651324-09-3 | C22H36N2O4 |
| Oseltamivir phosphate (impurity B-free) | 204255-11-8 | C16H31N2O8P |
| Oseltamivir Phosphate EP Impurity C HCl | 1415963-60-8 | C14H25ClN2O4 |
| Oseltamivir Phosphate EP Impurity E HCl | 208720-78-9 | C15H27ClN2O4 |
| Oseltamivir Phosphate Imp. H (EP): Tributylphosphane Oxide | 814-29-9 | C12H27OP |
| Oseltamivir Phosphate Impurity A | 1364932-19-3 | C14H24N2O4 |
| Oseltamivir Phosphate Impurity F | 1052063-37-2 | C15H26N2O4 |
| Oseltamivir Phosphate Impurity H | 814-29-9 | C12H27OP |
| Osimertinib impurity 10 | Not available | C56H66N14O4 |
| Osimertinib impurity 13 | 1421373-98-9 | C27H31N7O2 |
| Osimertinib impurity 14 | 2364486-23-5 | C13H10ClN3 |
| Osimertinib mesylate | 1421373-66-1 | C29H37N7O5S |
| Osteltamivir Phosphate | 204255-11-8 | C16H31N2O8P |
| Oxacillin for peak identification | 7240-38-2 | C19H20N3NaO6S |
| Oxacillin Impurity 2 | 36231-30-8 | C19H19N3O6S |
| Oxacillin Impurity F | 5053-35-0 | C19H19N3O4S2 |
| Oxacillin Impurity G | 724695-30-1 | C19H18ClN3O5S |
| Oxacillin peak discrimination | 7240-38-2 | C19H20N3NaO6S |
| Oxacillin Related Compound C | 1136-45-4 | C11H9NO3 |
| Oxacillin sodium EP Impurity B | 1642629-95-5 | C19H21N3O6S |
| Oxacillin sodium EP Impurity C | 1136-45-4 | C11H9NO3 |
| Oxacillin Sodium Imp. A (EP): (2S,5R,6R)-6-Amino-3,3-dimethyl- 7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2- carboxylic Acid (6-Aminopenicillanic Acid) | 551-16-6 | C8H12N2O3S |
| Oxacillin Sodium Imp. C (EP): 5-Methyl-3-phenylisoxazole-4-carboxylic | 1136-45-4 | C11H9NO3 |
| Oxacillin Sodium Imp. E (EP) as Sodium Salt Monohydrate: Cloxacillin Sodium Monohydrate | 7081-44-9 | C19H19ClN3NaO6S |
| Oxalic acid | 144-62-7 | C2H2O4 |
| Oxalic Acid-(1,2-13C2) | Not available | C2H2O4 |
| Oxaliplatin EP Impurity D | 61758-77-8 | C8H14N2O4Pt |
| Oxaliplatin Imp. A (EP) as Dihydrate: Ethanedioic Acid Dihydrate (Oxalic Acid Dihydrate) | 6153-56-6 | C2H6O6 |
| Oxaliplatin Impurity 2 | 66900-68-3 | C6H12N4O6Pt |
| Oxaliplatin impurity B | 1613271-93-4 | C20H32N2O8PtS2 |
| Oxaliplatin impurity C | 111321-67-6 | C8H16N2O6Pt |
| Oxaliplatin impurity C | 111321-67-6 | C8H14N2O6Pt |
| Oxaliplatin impurity C | Not available | C8H14N2O6Pt-2 |
| Oxaliplatin impurity D | 61758-77-8 | C8H14N2O4Pt |
| Oxaliplatin Related Compound A (oxalic acid dihydrate) | Not available | C2H6O6 |
| Oxaliplatin Related Compound C | 111321-67-6 | C8H14N2O6Pt |
| Oxaliplatin Related Compound F | 66845-32-7 | C6H12I2N2Pt |
| Oxaliplatin System Suitability | 61848-66-6 | C6H12Cl2N2Pt |
| Oxandrolone Related Compound B | 4424-45-7 | C19H30O3 |
| Oxandrolone Related Compound C | 142793-21-3 | C19H28O2 |
| Oxatomide N-Oxide | Not available | C27H30N4O2 |
| Oxatomide N-Oxide | 2726534-33-2 | C27H30N4O2 |
| Oxazepam EP Impurity B | 1824-74-4 | C17H13ClN2O3 |
| Oxazepam EP Impurity C | 5958-05-4 | C19H16O4 |
| Oxazepam EP impurity D | 719-59-5 | C13H10ClNO |
| Oxazepam EP Impurity E | 963-39-3 | C15H11ClN2O2 |
| Oxazepam for peak identification | 604-75-1 | C15H11ClN2O2 |
| Oxazepam Imp. D (EP): (2-Amino-5-chloro- phenyl)phenylmethanone (2-Amino-5-chlorobenzophenone) | 719-59-5 | C13H10ClNO |
| Oxazepam Imp. E (EP): 7-Chloro-5-phenyl-1,3-dihydro- 2H-1,4-benzodiazepin-2-one 4-Oxide (Demoxepam) | 963-39-3 | C15H11ClN2O2 |
| Oxazepam Related Compound A | 19554-95-1 | C15H11ClN2O2 |
| Oxazepam Related Compound B | 1824-74-4 | C17H13ClN2O3 |
| Oxazepam Related Compound C | 5958-05-4 | C19H16O4 |
| Oxcarbazepine EP Impurity A (Carbamazepine) | 298-46-4 | C15H12N2O |
| Oxcarbazepine EP Impurity B | 28721-09-7 | C16H14N2O2 |
| Oxcarbazepine EP Impurity C | 21737-58-6 | C14H11NO |
| Oxcarbazepine EP Impurity D | 19579-83-0 | C14H9NO2 |
| Oxcarbazepine EP Impurity F | 28721-08-6 | C16H12ClNO2 |
| Oxcarbazepine EP Impurity G | 15882-79-8 | C17H17NO |
| Oxcarbazepine EP Impurity H | 4698-11-7 | C15H13NO |
| Oxcarbazepine EP Impurity I | 537693-29-1 | C15H10N2O3 |
| Oxcarbazepine EP Impurity K | 1346601-76-0 | C16H12N2O3 |
| Oxcarbazepine EP Impurity L | 2642430-28-0 | C17H14N2O3 |
| Oxcarbazepine EP Impurity M | Not available | C30H22N4O3 |
| Oxcarbazepine Imp. A (EP): 5H-Dibenzo[b,f]azepine-5-carboxamide (Carbamazepine) | 298-46-4 | C15H12N2O |
| Oxcarbazepine Imp. C (EP): 5,11-Dihydro-10H-dibenzo[b,f]azepin-10-one (10- Ketoiminodibenzyl; 10-Oxo-10,11-dihydro-5H-dibenz[b,f] azepine) | 21737-58-6 | C14H11NO |
| Oxcarbazepine Imp. E (EP): 5H-Dibenzo[b,f]azepine | 256-96-2 | C14H11N |
| Oxcarbazepine Imp. F (EP): 10-Methoxy-5H-dibenzo[b,f]azepine-5-carbonyl Chloride | 28721-08-6 | C16H12ClNO2 |
| Oxcarbazepine impurity 1 | 2642430-30-4 | C16H13N3O3 |
| Oxcarbazepine impurity 5 | 10423-37-7 | C16H13NO |
| Oxcarbazepine impurity 17 | 578-95-0 | C13H9NO |
| Oxcarbazepine N-Sulfate | 1159977-54-4 | C15H12N2O5S |
| Oxcarbazepine Related Compound A | 1346601-76-0 | C16H12N2O3 |
| Oxcarbazepine Related Compound C | 578-95-0 | C13H9NO |
| Oxcarbazepine Related Compound C (Acridin-9(10H)-one) | Not available | C13H9NO |
| Oxcarbazepine Related Compound E | 21737-58-6 | C14H11NO |
| oxecan-2-one | 6008-27-1 | C9H16O2 |
| Oxeladin EP Impurity A | 140-82-9 | C8H19NO2 |
| Oxeladin Hydrogen Citrate Imp. A (EP): 2-[2-(Diethylamino)ethoxy]ethanol | 140-82-9 | C8H19NO2 |
| Oxeladin impurity C | Not available | C18H29NO2 |
| Oxeladin impurity D | 18109-81-4 | C24H37NO10 |
| Oxeladin N-Oxide | Not available | C20H33NO4 |
| Oxeladin N-Oxide | 1812854-79-7 | C20H33NO4 |
| Oxfendazole Imp. B (EP): Methyl [5-(Phenylsulphonyl)- 1H-benzimidazol-2-yl]carbamate (Fenbendazole Sulphone) | 54029-20-8 | C15H13N3O4S |
| Oxfendazole impurity B | 54029-20-8 | C15H13N3O4S |
| Oxfendazole with impurity D | 53716-50-0 | C15H13N3O3S |
| Oxiconazole Related Compound B | 64211-06-9 | C11H9Cl2N3O |
| Oxiracetam Impurity 4 | 68252-28-8 | C6H10N2O3 |
| oxiracetam impurity I | 106-57-0 | C4H6N2O2 |
| oxiracetam impurity II | 120428-80-0 | C8H13N3O4 |
| oxiracetam impurity III | 62833-66-3 | C6H8N2O2 |
| oxiracetam impurity IV | 77191-37-8 | C6H9NO4 |
| oxiracetam impurity VI | 85614-52-4 | C7H11NO4 |
| oxiracetam impurity VII | 62613-81-4 | C8H13NO4 |
| Oxiracetam Impurity Ⅷ | 25747-41-5 | C4H7NO2 |
| Oxitropium bromide impurity B | 155-41-9 | C18H24BrNO4 |
| Oxitropium bromide impurity D | 95778-01-1 | C19H24BrNO3 |
| Oxo-MDV 3100 (Oxo-enzalutamide) | 1242137-18-3 | C21H16F4N4O3 |
| Oxociprofloxacin | 103237-52-1 | C17H16FN3O4 |
| Oxolinic acid ethyl ester | 16172-03-5 | C15H15NO5 |
| Oxolinic Acid Imp. B (EP): Ethyl 5-Ethyl-8-oxo-5,8-dihydro-1,3-dioxolo[4,5-g] quinoline-7-carboxylate (Oxolinic Acid Ethyl Ester) | 16172-03-5 | C15H15NO5 |
| Oxolinic acid impurity A | 26893-27-6 | C11H7NO5 |
| Oxolinic acid impurity A | Not available | C11H7NO5 |
| Oxolinic acid impurity B | 16172-03-5 | C15H15NO5 |
| Oxolinic acid impurity B | 16172-03-5 | C15H15NO5 |
| Oxolinic Acid Isopropyl Ester | Not available | C16H17NO5 |
| Oxolinic Acid Methyl Ester | 50332-56-4 | C14H13NO5 |
| Oxophenylacetic Acid (Benzoylformic Acid) | 611-73-4 | C8H6O3 |
| Oxozolpidem (N,N,6-Trimethyl-2-(4-methyl- phenyl)- -oxo-imidazo[1,2-a]pyridine-3- acetamide) | 400038-68-8 | C19H19N3O2 |
| Oxozolpidem (N,N,6-Trimethyl-2-(4-methylphenyl)-alpha-oxo-imidazo[1,2-a]pyridine-3-acetamide) | 400038-68-8 | C19H19N3O2 |
| Oxybuprocaine | 99-43-4 | C17H28N2O3 |
| Oxybuprocaine Hydrochloride Imp. A (EP): 4-Aminobenzoic Acid | 150-13-0 | C7H7NO2 |
| Oxybuprocaine Hydrochloride Imp. B (EP): 4-Amino-3-butoxybenzoic Acid | 23442-22-0 | C11H15NO3 |
| Oxybuprocaine Hydrochloride Imp. C (EP): 4-Amino-3-hydroxybenzoic Acid | 2374-03-0 | C7H7NO3 |
| Oxybuprocaine N-Oxide Dihydrochloride | Not available | C17H29ClN2O4 |
| Oxybutynin Hydrochloride Imp. B (EP): 4-(Diethylamino)but-2-ynyl 2-Hydroxy-2,2-diphenylacetate (Diphenyl Analogue of Oxybutynin) | 14943-53-4 | C22H25NO3 |
| Oxybutynin Hydrochloride Imp. D (EP): (RS)-2-Cyclohexyl-2- hydroxy-2-phenylacetic Acid (Phenylcyclohexylglycolic Acid) | 4335-77-7 | C14H18O3 |
| Oxybutynin impurity 1 | 81039-77-2 | C20H28ClNO3 |
| Oxybutynin Related Compound A | 4335-77-7 | C14H18O3 |
| Oxybutynin Related Compound A (Phenylcyclohexylglycolic Acid) | Not available | C14H18O3 |
| Oxybutynin Related Compound B | 10399-13-0 | C15H20O3 |
| Oxybutynin Related Compound C | 1199574-70-3 | C21H29NO3 |
| oxychlordan | 27304-13-8 | C10H4Cl8O |
| Oxyclozanide | 550-89-0 | C13H9N3O |
| Oxycodone hydrochloride EP impurity C/Hydroxycodone hydrochloride EP impurity C | 52446-25-0 | C17H20ClNO4 |
| Oxycodone hydrochloride EP impurity D | Not available | C18H19NO4 |
| Oxycodone Hydrochloride Imp. C (EP) as Hydrochloride: 4,5 -Epoxy-14- hydroxy-3-methoxymorphinan-6-one Hydrochloride (Noroxycodone Hydrochloride) | 52446-25-0 | C17H20ClNO4 |
| Oxycodone Hydrochloride Imp. D (EP): 7,8-Didehydro-4,5 -epoxy-14-hydroxy-3-methoxy- 17-methylmorphinan-6-one (14-Hydroxycodeinone) | 508-54-3 | C18H19NO4 |
| Oxycodone impurity D | 508-54-3 | C18H19NO4 |
| Oxycodone N-Oxide | 71539-52-1 | C18H21NO5 |
| Oxycodone Related Compound A | 508-54-3 | C18H19NO4 |
| Oxycodone Related Compound B | 71539-52-1 | C18H21NO5 |
| Oxycodone Related Compound B (Oxycodone N-oxide) | 71539-52-1 | C18H21NO5 |
| Oxycodone Related Compound C | 467-13-0 | C18H19NO3 |
| Oxydibenzene | 101-84-8 | C12H10O |
| Oxymetazoline | 1491-59-4 | C16H24N2O |
| Oxymetazoline Hydrochloride EP impurity A | 1391194-44-7 | C16H26N2O2 |
| Oxymetazoline Hydrochloride EP impurity B | 526-36-3 | C16H24N2 |
| Oxymetazoline Hydrochloride EP impurity C | 55699-13-3 | C14H21NO2 |
| Oxymetazoline Hydrochloride EP impurity D | 55699-12-2 | C14H20O3 |
| Oxymetazoline Hydrochloride EP impurity E | 55699-10-0 | C14H19NO |
| Oxymetazoline Hydrochloride Imp. A (EP) as Hydrochloride: N-(2-Amino- ethyl)-2-[4-(1,1-dimethylethyl)-3-hydroxy- 2,6-dimethylphenyl]acetamide Hydrochloride | 1391053-50-1 | C16H27ClN2O2 |
| Oxymetazoline Hydrochloride Imp. B (EP) as Hydrochloride: Xylometazoline Hydrochloride | 1218-35-5 | C16H25ClN2 |
| Oxymetazoline Hydrochloride Imp. C (EP): 2-[4-(1,1-Dimethylethyl)-3- hydroxy-2,6-dimethylphenyl]acetamide | 55699-13-3 | C14H21NO2 |
| Oxymetazoline Hydrochloride Imp. D (EP): [4-(1,1-Dimethylethyl)-3-hydroxy- 2,6-dimethylphenyl]acetic Acid | 55699-12-2 | C14H20O3 |
| Oxymetazoline Hydrochloride Imp. E (EP): [4-(1,1-Dimethylethyl)-3-hydroxy- 2,6-dimethylphenyl]acetonitrile | 55699-10-0 | C14H19NO |
| Oxymetazoline impurity A | 1391194-44-7 | C16H26N2O2 |
| Oxyphenisatin Diacetate Impurity 1 | 2910823-02-6 | C24H18ClNO5 |
| Oxypurinol | 2465-59-0 | C5H4N4O2 |
| Oxyquinol Reference Spectrum | 148-24-3 | C9H7NO |
| Oxytetracycline EP impurity A | 14206-58-7 | C22H24N2O9 |
| Oxytetracycline EP impurity B | 60-54-8 | C22H24N2O8 |
| Oxytetracycline EP impurity D | 18695-01-7 | C22H22N2O8 |
| Oxytetracycline EP impurity E | 18751-99-0 | C22H22N2O8 |
| Oxytetracycline EP impurity F | 4660-26-8 | C22H22N2O8 |
| Oxytetracycline for system suitability A | 79-57-2 | C22H24N2O9 |
| Oxytetracycline Hydrochloride Imp. A (EP): (4R,4aR,5S,5aR,6S,12aS)-4-(Dimethylamino)- 3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo- 1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide (4- Epioxytetracycline) | 14206-58-7 | C22H24N2O9 |
| Oxytetracycline Hydrochloride Imp. B (EP) as Hydrochloride: Tetracycline Hydrochloride | 64-75-5 | C22H25ClN2O8 |
| Oxytetracycline impurity 1 | 7647-65-6 | C23H25NO9 |
| Oxytocin | Not available | C43H66N12O12S2 |
| Oxytocin | 50-56-6 | C43H66N12O12S2 |
| Ozagrel | 82571-53-7 | C13H12N2O2 |
| Ozagrel Impurity 2 | 100688-45-7 | C13H14O4 |
| Ozagrel Impurity 3 | 883903-90-0 | C13H11N2NaO2 |
| Ozagrel Impurity 5 | 24393-49-5 | C12H14O2 |
| Ozagrel Impurity 6 | 78712-67-1 | C12H13BrO2 |
| Ozagrel Impurity 10 | 78712-80-8 | C15H16N2O2 |
| Ozagrel Impurity 11 | 956932-46-0 | C14H14N2O2 |
| Ozagrel Impurity 12 | 74003-18-2 | C13H13ClN2O2 |
| Ozagrel Impurity 15 | 1332370-00-9 | C10H10O3 |
| Ozagrel Impurity 23 HCl | 67688-89-5 | C10H12ClNO2 |
| Ozagrel Impurity 35 | 7560-50-1 | C11H10O3 |
| Ozagrel Impurity 38 | 20754-20-5 | C11H12O2 |
| Ozagrel Impurity 41 | 95416-56-1 | C11H12O2 |
| Ozagrel Impurity 42 | 3901-07-3 | C11H12O3 |
| Ozagrel Impurity 44 | 83993-01-5 | C13H15ClN2O3 |
| Ozagrel Impurity 45 | 189224-26-8 | C13H11N2NaO2 |
| Ozagrel Impurity A | 7560-43-2 | C11H12O2 |
| Ozamide hydrochloride (R) | 1306760-85-9 | C23H25ClN4O3 |
| Ozanimod hydrochloride | 1618636-37-5 | C23H25ClN4O3 |
| Ozenoxacin | 245765-41-7 | C21H21N3O3 |
| Ozenoxacin Impurity 4 | Not available | C16H17Cl2NO3 |
| Ozenoxacin Impurity 6 | 245765-66-6 | C7H9BrN2 |
| Ozenoxacin Impurity 7 | 856836-09-4 | C14H14N2O |
| Ozenoxacin Impurity 8 | 29241-60-9 | C6H5BrClN |
| Ozenoxacin Impurity 10 | 103877-20-9 | C14H12ClNO3 |
| Ozenoxacin Impurity 15 | 446299-81-6 | C14H15BN2O3 |
| Ozenoxacin Impurity 16 | 1111637-92-3 | C13H21BN2O2 |
| Ozenoxacin Impurity 25 | 302948-99-8 | C13H12ClNO3 |
| Ozenoxacin Impurity 27 | 446299-90-7 | C30H29N3O4 |
| P-[(1R,2R)-1,2-Dihydroxypropyl]-phosphonic Acid Ammonium Salt | 1160525-87-0 | C3H15N2O5P |
| P-aminohippuric acid | 61-78-9 | C9H10N2O3 |
| p-Anisaldehyde | 123-11-5 | C8H8O2 |
| p-Benzoquinona | 106-51-4 | C6H4O2 |
| P-bromofluorobenzene | 460-00-4 | C6H4BrF |
| p-Butyl Ibuprofen Sodium Salt | Not available | C13H17NaO2 |
| p-Butyl Ibuprofen-d3 Sodium Salt | Not available | C13H17NaO2 |
| P-formyl Methyl benzoate | 1571-08-0 | C9H8O3 |
| P-hydroxybenzoyl chloride | 28141-24-4 | C7H5ClO2 |
| P-hydroxyphenylacetic acid | 156-38-7 | C8H8O3 |
| P-mentha-1,2,8-triol | 62014-81-7 | C10H20O3 |
| p-methyl cinnamic acid | 1866-39-3 | C10H10O2 |
| P-methylphenylhydrazine | 539-44-6 | C7H10N2 |
| p-Nicorandil | 65141-47-1 | C8H9N3O4 |
| p-Nitrobenzyl 6-(1'-Hydroxyethyl)-azabicyclo(3.2.0)heptane-3,7-dione-2-carboxylate | 74288-40-7 | C16H16N2O7 |
| P-nitrophenylacetic acid | 104-03-0 | C8H7NO4 |
| p-Ranolazine | Not available | C24H33N3O4 |
| p-Toluenesulfonamide | 70-55-3 | C7H9NO2S |
| p-Torasemide (1-(1-Methylethyl)-3-[(4-[(4-methylphenyl)amino]pyridin-3-yl)sulfonyl]urea) | 106944-63-2 | C16H20N4O3S |
| p-Torasemide (1-(1-Methylethyl)-3-[[4-[(4-methylphenyl)amino] pyridin-3-yl]sulfonyl]urea) | 106944-63-2 | C16H20N4O3S |
| p-Torasemide (1-(1-Methylethyl)-3-[[4-[(4-methylphenyl)amino]pyridin-3-yl]sulfonyl]urea) | 106944-63-2 | C16H20N4O3S |
| P-trifluoromethanesulfonate | 29702-90-7 | C4H7F3O3S |
| Pacetinib citrate | 1228923-42-9 | C34H40N4O10 |
| Paclitaxel EP Impurity A | 173101-54-7 | C45H53NO14 |
| Paclitaxel EP Impurity B | 71610-00-9 | C45H53NO14 |
| Paclitaxel EP Impurity C | 153415-45-3 | C46H57NO14 |
| Paclitaxel EP Impurity D | 150547-36-7 | C45H53NO14 |
| Paclitaxel EP Impurity E | 105454-04-4 | C47H51NO14 |
| Paclitaxel EP Impurity F | 153083-53-5 | C47H59NO14 |
| Paclitaxel EP Impurity G | 78432-77-6 | C45H49NO13 |
| Paclitaxel EP Impurity H | 78454-17-8 | C45H49NO13 |
| Paclitaxel EP Impurity I | 2157462-42-3 | C61H62N2O16 |
| Paclitaxel EP Impurity J | 2757197-26-3 | C49H53NO15 |
| Paclitaxel EP Impurity J | Not available | C49H53NO15 |
| Paclitaxel EP Impurity K | 148930-55-6 | C53H65NO14Si |
| Paclitaxel EP Impurity L | 92950-39-5 | C49H53NO15 |
| Paclitaxel EP Impurity N | 27548-93-2 | C31H38O11 |
| Paclitaxel EP Impurity O | 219783-77-4 | C49H53NO14 |
| Paclitaxel EP Impurity P | 173101-56-9 | C48H53NO14 |
| Paclitaxel EP Impurity Q | 502626-06-4 | C46H55NO14 |
| Paclitaxel EP Impurity R | Not available | C45H55NO14 |
| Paclitaxel Imp. B (EP): N-Debenzoyl-N-tigloylpaclitaxel (Cephalomannine) | 71610-00-9 | C45H53NO14 |
| Paclitaxel Imp. N (EP): 13-O-De[(2R,3S)-3-(benzoylamino)-2-hydroxy-3- phenylpropanoyl]paclitaxel (Baccatin III) | 27548-93-2 | C31H38O11 |
| Paclitaxel Impurity 5 | 92950-42-0 | C29H34O10 |
| Paclitaxel Impurity 5 | 172018-16-5 | C29H36O10 |
| Paclitaxel Impurity 6 | 71629-92-0 | C29H36O10 |
| Paclitaxel Impurity 7 | 90332-67-5 | C51H65NO18 |
| Paclitaxel Impurity 21 | 146139-03-9 | C47H51NO14 |
| Paclitaxel Impurity 22 (Docetaxel Impurity 12) | 165173-47-7 | C29H36O10 |
| Paclitaxel Impurity 23 | 208406-86-4 | C37H52O11Si |
| Paclitaxel Impurity 35 | 153212-75-0 | C47H51NO15 |
| Paclitaxel Impurity 36 (Larotaxel) | 156294-36-9 | C45H53NO14 |
